Obiettivo
The overarching aims of the DIRECT consortium, consisting of 20 leading academic groups in diabetes and 5 EFPIA companies, are to identify biomarkers that address current bottlenecks in diabetes drug development and to develop a stratified medicines approach to treatment of type 2 diabetes with either existing or novel therapies.
There is heterogeneity in who develops diabetes, the rate at which their subsequent diabetes progresses, how they respond to diabetes therapy and who develops micro- and macrovascular complications. In the DIRECT consortium we propose to identify biomarkers to identify subtypes with rapid diabetes development and progression and altered response to diabetes treatments, and develop and use these biomarkers in clinical trials.
Two phenotyping work packages will focus on glycaemic deterioration and therapeutic response. For each, the DIRECT consortium brings considerable existing resource, which will be augmented by large-scale prospective cohort collection with intensive physiological and imaging phenotyping. Additional data will be added, such as existing studies on acute response to intravenous beta-cell secretagogues, and functional genomics on human islets, liver, muscle and adipose tissue, to maximise the power and utility of an innovative integrated biology approach. To enable computational multi-level integration across phenotypes and data types, a robust and secure data repository will be developed with strict data governance. As the ultimate aim of DIRECT is patient stratification, biomarkers arising from the discovery work will be used to design one or more prospective clinical trials. These will validate the biomarker(s) of interest, and establish utility in clinical practice and/or trial design and drug development. As a result, this consortium offers considerable potential to achieve major progress towards a personalized medicines approach to the treatment of type 2 diabetes.
Campo scientifico
Invito a presentare proposte
IMI-JU-03-2010
Vedi altri progetti per questo bando
Meccanismo di finanziamento
JTI-CP-IMI - Joint Technology Initiatives - Collaborative Project (IMI)Coordinatore
65929 Frankfurt Am Main
Germania
Mostra sulla mappa
Partecipanti (25)
DD1 4HN Dundee
Mostra sulla mappa
BA2 7AY Bath
Mostra sulla mappa
00185 Roma
Mostra sulla mappa
2800 Kongens Lyngby
Mostra sulla mappa
72074 Tuebingen
Mostra sulla mappa
85764 Neuherberg
Mostra sulla mappa
08036 Barcelona
Mostra sulla mappa
SW7 2AZ LONDON
Mostra sulla mappa
100 44 Stockholm
Mostra sulla mappa
75794 Paris
Mostra sulla mappa
2333 ZA Leiden
Mostra sulla mappa
1165 Kobenhavn
Mostra sulla mappa
70211 KUOPIO
Mostra sulla mappa
22100 Lund
Mostra sulla mappa
NE1 7RU Newcastle Upon Tyne
Mostra sulla mappa
EX4 4QJ Exeter
Mostra sulla mappa
1211 Geneve
Mostra sulla mappa
OX1 2JD Oxford
Mostra sulla mappa
89081 Ulm
Mostra sulla mappa
1081 HV Amsterdam
Mostra sulla mappa
2880 Bagsvaerd
Mostra sulla mappa
RG21 4FA Basingstoke
Mostra sulla mappa
92284 Courbevoie
Mostra sulla mappa
59037 Lille
Mostra sulla mappa
55218 Ingelheim
Mostra sulla mappa